RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway

Abstract Backround RPL15 has been found to participate in human tumorigenesis. However, its function and regulatory mechanism in hepatocellular carcinoma (HCC) development are still unclear. Current study investigated the effects of RPL15 in HCC. Methods The expression of RPL15 in clinical tissues a...

Full description

Bibliographic Details
Main Authors: Rui Shi, Zirong Liu
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-022-02555-5
_version_ 1818022182430703616
author Rui Shi
Zirong Liu
author_facet Rui Shi
Zirong Liu
author_sort Rui Shi
collection DOAJ
description Abstract Backround RPL15 has been found to participate in human tumorigenesis. However, its function and regulatory mechanism in hepatocellular carcinoma (HCC) development are still unclear. Current study investigated the effects of RPL15 in HCC. Methods The expression of RPL15 in clinical tissues and cell lines of HCC was detected by RT-qPCR, Western blotting, and Immunohistochemistry (IHC). Colony formation, CCK-8, flow cytometry, Wound healing and Transwell invasion assays, were used to detect the carcinoma progression of HCC cells with RPL15 overexpression or knockdown in vitro. A xenograft model was constructed to assess the effect of RPL15 knockdown on HCC cells in vivo. The expression of CDK2 and Cyclin E1 related to cell cycles, Bax and Bcl-2 related to cell apoptosis, E-cadherin, N-cadherin and Vimentin related to epithelial–mesenchymal transition (EMT), p53 and p21 related to p53 signaling pathway, were detected by Western blotting. The connection between p53, MDM2 and RPL5/11 affected by RPL15 was analyzed using immunoprecipitation and Cycloheximide (CHX) chase assay. Results Elevated RPL15 was identified in HCC tissues, which was not only a prediction for the poor prognosis of HCC patients, but also associated with the malignant progression of HCC. RPL15 silencing arrested HCC cell cycle, suppressed HCC cell colony formation, proliferation, invasion, and migration, and induce cell apoptosis. On the contrary, RPL15 upregulation exerted opposite effects. Results also indicated that HCC cell invasion and migration were associated with EMT, and that the RPs-MDM2-p53 pathway was implicated in RPL15-mediated oncogenic transformation. In addition, RPL15 knockdown significantly suppressed HCC xenografts growth. Conclusions RPL15 played crucial roles in HCC progression and metastasis, serving as a promising candidate for targeted therapies.
first_indexed 2024-04-14T08:28:03Z
format Article
id doaj.art-6db7344eb6c74f029116734a804a7ed3
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-14T08:28:03Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-6db7344eb6c74f029116734a804a7ed32022-12-22T02:03:59ZengBMCCancer Cell International1475-28672022-04-0122111310.1186/s12935-022-02555-5RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathwayRui Shi0Zirong Liu1Department of Hepatobiliary Surgery, Tianjin First Central HospitalDepartment of Hepatobiliary Surgery, Tianjin First Central HospitalAbstract Backround RPL15 has been found to participate in human tumorigenesis. However, its function and regulatory mechanism in hepatocellular carcinoma (HCC) development are still unclear. Current study investigated the effects of RPL15 in HCC. Methods The expression of RPL15 in clinical tissues and cell lines of HCC was detected by RT-qPCR, Western blotting, and Immunohistochemistry (IHC). Colony formation, CCK-8, flow cytometry, Wound healing and Transwell invasion assays, were used to detect the carcinoma progression of HCC cells with RPL15 overexpression or knockdown in vitro. A xenograft model was constructed to assess the effect of RPL15 knockdown on HCC cells in vivo. The expression of CDK2 and Cyclin E1 related to cell cycles, Bax and Bcl-2 related to cell apoptosis, E-cadherin, N-cadherin and Vimentin related to epithelial–mesenchymal transition (EMT), p53 and p21 related to p53 signaling pathway, were detected by Western blotting. The connection between p53, MDM2 and RPL5/11 affected by RPL15 was analyzed using immunoprecipitation and Cycloheximide (CHX) chase assay. Results Elevated RPL15 was identified in HCC tissues, which was not only a prediction for the poor prognosis of HCC patients, but also associated with the malignant progression of HCC. RPL15 silencing arrested HCC cell cycle, suppressed HCC cell colony formation, proliferation, invasion, and migration, and induce cell apoptosis. On the contrary, RPL15 upregulation exerted opposite effects. Results also indicated that HCC cell invasion and migration were associated with EMT, and that the RPs-MDM2-p53 pathway was implicated in RPL15-mediated oncogenic transformation. In addition, RPL15 knockdown significantly suppressed HCC xenografts growth. Conclusions RPL15 played crucial roles in HCC progression and metastasis, serving as a promising candidate for targeted therapies.https://doi.org/10.1186/s12935-022-02555-5Hepatocellular carcinomaMDM2p53RPL15Tumor progression
spellingShingle Rui Shi
Zirong Liu
RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
Cancer Cell International
Hepatocellular carcinoma
MDM2
p53
RPL15
Tumor progression
title RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
title_full RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
title_fullStr RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
title_full_unstemmed RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
title_short RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
title_sort rpl15 promotes hepatocellular carcinoma progression via regulation of rps mdm2 p53 signaling pathway
topic Hepatocellular carcinoma
MDM2
p53
RPL15
Tumor progression
url https://doi.org/10.1186/s12935-022-02555-5
work_keys_str_mv AT ruishi rpl15promoteshepatocellularcarcinomaprogressionviaregulationofrpsmdm2p53signalingpathway
AT zirongliu rpl15promoteshepatocellularcarcinomaprogressionviaregulationofrpsmdm2p53signalingpathway